Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Stem Cells | 5 | 2021 | 1348 | 0.560 |
Why?
|
Receptors, Estrogen | 5 | 2011 | 2208 | 0.380 |
Why?
|
GATA3 Transcription Factor | 2 | 2009 | 155 | 0.370 |
Why?
|
p300-CBP Transcription Factors | 1 | 2010 | 150 | 0.330 |
Why?
|
RNA Helicases | 3 | 2005 | 143 | 0.330 |
Why?
|
Receptor, PAR-2 | 1 | 2008 | 33 | 0.320 |
Why?
|
DEAD-box RNA Helicases | 4 | 2007 | 380 | 0.310 |
Why?
|
Homeodomain Proteins | 4 | 2011 | 2413 | 0.290 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 646 | 0.290 |
Why?
|
Repressor Proteins | 3 | 2008 | 2974 | 0.280 |
Why?
|
Limbus Corneae | 2 | 2022 | 143 | 0.280 |
Why?
|
Melanoma | 6 | 2016 | 5694 | 0.270 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3594 | 0.270 |
Why?
|
Fluorouracil | 1 | 2011 | 1642 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5300 | 0.260 |
Why?
|
Histone Deacetylases | 2 | 2010 | 716 | 0.230 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7574 | 0.230 |
Why?
|
Ethers | 1 | 2024 | 73 | 0.230 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 582 | 0.230 |
Why?
|
Mice, Inbred NOD | 5 | 2018 | 1822 | 0.220 |
Why?
|
Mice, SCID | 5 | 2020 | 2621 | 0.210 |
Why?
|
Adenosine Triphosphatases | 2 | 2004 | 833 | 0.210 |
Why?
|
Protein Kinases | 3 | 2005 | 1607 | 0.210 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3776 | 0.210 |
Why?
|
Amines | 1 | 2024 | 280 | 0.200 |
Why?
|
Promoter Regions, Genetic | 5 | 2011 | 5775 | 0.190 |
Why?
|
Databases, Genetic | 1 | 2007 | 1741 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2018 | 8529 | 0.180 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6919 | 0.180 |
Why?
|
Activin Receptors, Type I | 1 | 2020 | 134 | 0.170 |
Why?
|
Trans-Activators | 3 | 2010 | 2846 | 0.170 |
Why?
|
Epithelium, Corneal | 1 | 2022 | 252 | 0.170 |
Why?
|
Fibroblasts | 2 | 2008 | 4137 | 0.160 |
Why?
|
Antibodies, Neoplasm | 1 | 2020 | 282 | 0.160 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3409 | 0.150 |
Why?
|
Cell Line, Tumor | 9 | 2020 | 16947 | 0.150 |
Why?
|
Gene Expression Regulation | 5 | 2011 | 11856 | 0.140 |
Why?
|
Nuclear Proteins | 2 | 2008 | 5781 | 0.130 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2015 | 24 | 0.130 |
Why?
|
Adenocarcinoma | 2 | 2011 | 6340 | 0.130 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2016 | 87 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 736 | 0.130 |
Why?
|
Receptors, Interleukin-8A | 1 | 2014 | 47 | 0.120 |
Why?
|
Mice | 17 | 2020 | 81324 | 0.110 |
Why?
|
COS Cells | 3 | 2011 | 1129 | 0.110 |
Why?
|
Microarray Analysis | 2 | 2014 | 748 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2802 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3591 | 0.110 |
Why?
|
Transfection | 3 | 2014 | 5750 | 0.110 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2007 | 858 | 0.100 |
Why?
|
Pigmentation | 1 | 2013 | 143 | 0.100 |
Why?
|
Phospholipids | 1 | 2016 | 784 | 0.100 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2010 | 292 | 0.100 |
Why?
|
Genes, Reporter | 2 | 2008 | 1520 | 0.100 |
Why?
|
Models, Biological | 1 | 2008 | 9455 | 0.100 |
Why?
|
Cell Movement | 2 | 2018 | 5195 | 0.100 |
Why?
|
Cell Line | 6 | 2010 | 15542 | 0.100 |
Why?
|
Joint Diseases | 1 | 2015 | 460 | 0.100 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2016 | 328 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2018 | 10421 | 0.090 |
Why?
|
Animals | 20 | 2021 | 168083 | 0.090 |
Why?
|
Interleukin-8 | 1 | 2014 | 696 | 0.090 |
Why?
|
Melanins | 1 | 2013 | 289 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 563 | 0.090 |
Why?
|
Amino Acids | 1 | 2016 | 1703 | 0.090 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 849 | 0.090 |
Why?
|
Signal Transduction | 2 | 2014 | 23415 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3779 | 0.080 |
Why?
|
Protein Binding | 4 | 2011 | 9300 | 0.080 |
Why?
|
Apoptosis | 4 | 2020 | 9478 | 0.080 |
Why?
|
Matrix Metalloproteinase 10 | 1 | 2008 | 11 | 0.080 |
Why?
|
Skin Neoplasms | 3 | 2016 | 5809 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3499 | 0.080 |
Why?
|
Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
Interleukin-1alpha | 1 | 2008 | 86 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 1002 | 0.080 |
Why?
|
Trypsin | 1 | 2008 | 486 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2010 | 873 | 0.070 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2007 | 68 | 0.070 |
Why?
|
Acetylation | 1 | 2010 | 1050 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 558 | 0.070 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 668 | 0.070 |
Why?
|
Immunoblotting | 1 | 2010 | 1644 | 0.070 |
Why?
|
Stem Cells | 2 | 2022 | 3512 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2008 | 1696 | 0.070 |
Why?
|
Binding Sites | 4 | 2008 | 5993 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2009 | 20981 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2008 | 597 | 0.070 |
Why?
|
Regeneration | 1 | 2014 | 1505 | 0.060 |
Why?
|
Mice, Knockout | 5 | 2016 | 14393 | 0.060 |
Why?
|
Glioblastoma | 1 | 2020 | 3481 | 0.060 |
Why?
|
Quality Control | 1 | 2007 | 834 | 0.060 |
Why?
|
S Phase | 1 | 2006 | 422 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4341 | 0.060 |
Why?
|
Genomics | 2 | 2021 | 5828 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5662 | 0.060 |
Why?
|
Thymidine Kinase | 1 | 2004 | 286 | 0.060 |
Why?
|
Simian virus 40 | 1 | 2004 | 291 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2010 | 943 | 0.060 |
Why?
|
Chromatography, Gel | 1 | 2004 | 642 | 0.060 |
Why?
|
Histone Deacetylase 1 | 1 | 2004 | 133 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2010 | 2820 | 0.050 |
Why?
|
Wound Healing | 1 | 2014 | 2801 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2189 | 0.050 |
Why?
|
Sequence Deletion | 2 | 2004 | 1487 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1668 | 0.050 |
Why?
|
Humans | 25 | 2024 | 761098 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7567 | 0.050 |
Why?
|
Genes, myc | 1 | 2002 | 390 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4565 | 0.050 |
Why?
|
Herpes Simplex | 1 | 2004 | 465 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2004 | 614 | 0.040 |
Why?
|
Adenoviridae | 1 | 2004 | 1084 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2827 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13630 | 0.040 |
Why?
|
Hep G2 Cells | 2 | 2011 | 374 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2010 | 0.040 |
Why?
|
Neoplasms | 2 | 2007 | 22125 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8519 | 0.040 |
Why?
|
Genome | 1 | 2007 | 1737 | 0.040 |
Why?
|
RNA Interference | 3 | 2016 | 2816 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2877 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9025 | 0.040 |
Why?
|
Osteosarcoma | 1 | 2004 | 896 | 0.040 |
Why?
|
Liver | 2 | 2011 | 7513 | 0.040 |
Why?
|
Mice, Nude | 3 | 2010 | 3604 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2004 | 1360 | 0.040 |
Why?
|
NF-kappa B | 2 | 2005 | 2475 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2002 | 987 | 0.030 |
Why?
|
Glycerylphosphorylcholine | 1 | 2016 | 25 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4353 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 2016 | 129 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2813 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1875 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3725 | 0.030 |
Why?
|
Lactates | 1 | 2016 | 401 | 0.030 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2016 | 105 | 0.030 |
Why?
|
HeLa Cells | 3 | 2007 | 3073 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3060 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2022 | 18926 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1330 | 0.030 |
Why?
|
Transcription Factors | 3 | 2014 | 12096 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 634 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2005 | 2914 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2003 | 2443 | 0.030 |
Why?
|
Heart | 1 | 2007 | 4431 | 0.030 |
Why?
|
Alanine | 1 | 2016 | 608 | 0.030 |
Why?
|
Hair Color | 1 | 2013 | 131 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 793 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1049 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2527 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17598 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2004 | 5103 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2022 | 11505 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4250 | 0.020 |
Why?
|
CLOCK Proteins | 1 | 2011 | 86 | 0.020 |
Why?
|
Male | 10 | 2020 | 360675 | 0.020 |
Why?
|
ARNTL Transcription Factors | 1 | 2011 | 96 | 0.020 |
Why?
|
Photoperiod | 1 | 2011 | 139 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1187 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6123 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3666 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 185 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3591 | 0.020 |
Why?
|
Regulon | 1 | 2010 | 71 | 0.020 |
Why?
|
Keratins, Type II | 1 | 2009 | 1 | 0.020 |
Why?
|
Keratins, Hair-Specific | 1 | 2009 | 1 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2011 | 9416 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2009 | 47 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20120 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8164 | 0.020 |
Why?
|
Bile Acids and Salts | 1 | 2011 | 393 | 0.020 |
Why?
|
Kidney | 1 | 2004 | 7034 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10758 | 0.020 |
Why?
|
Female | 8 | 2020 | 392458 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 1 | 2009 | 224 | 0.020 |
Why?
|
Pregnancy Proteins | 1 | 2009 | 222 | 0.020 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2007 | 30 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22157 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2009 | 470 | 0.020 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2007 | 21 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2011 | 22129 | 0.020 |
Why?
|
Glycolysis | 1 | 2011 | 836 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1658 | 0.020 |
Why?
|
Cell Membrane | 1 | 2016 | 3665 | 0.020 |
Why?
|
Cyclin A2 | 1 | 2006 | 21 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2006 | 38 | 0.020 |
Why?
|
Cyclin A | 1 | 2006 | 60 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1602 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3770 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2009 | 471 | 0.020 |
Why?
|
Centrifugation | 1 | 2006 | 122 | 0.020 |
Why?
|
Thymidine | 1 | 2006 | 296 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1600 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 925 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1718 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2009 | 1607 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13382 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 501 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1681 | 0.010 |
Why?
|
3T3 Cells | 1 | 2006 | 1083 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12727 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 30006 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2623 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2731 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5033 | 0.010 |
Why?
|
Cyclins | 1 | 2006 | 594 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2007 | 13404 | 0.010 |
Why?
|
Nuclear Factor 90 Proteins | 1 | 2003 | 3 | 0.010 |
Why?
|
Triglycerides | 1 | 2011 | 2457 | 0.010 |
Why?
|
Genes, ras | 1 | 2006 | 654 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8639 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 872 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2006 | 1750 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 713 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 812 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11066 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2902 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4473 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6857 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2003 | 460 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6198 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2003 | 1139 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2203 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2002 | 254 | 0.010 |
Why?
|
Dimerization | 1 | 2003 | 888 | 0.010 |
Why?
|
Motor Activity | 1 | 2011 | 2712 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9648 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6565 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3318 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4111 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4908 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2570 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2005 | 1751 | 0.010 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2003 | 725 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15845 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29672 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2005 | 1745 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6390 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6588 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8303 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2637 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16572 | 0.010 |
Why?
|
DNA Damage | 1 | 2005 | 2443 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2003 | 1855 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24013 | 0.010 |
Why?
|
DNA | 1 | 2007 | 7189 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39953 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15915 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54419 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2002 | 6507 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7844 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2003 | 2667 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12670 | 0.010 |
Why?
|
Adult | 2 | 2015 | 221083 | 0.010 |
Why?
|
Risk Factors | 1 | 2013 | 74219 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9566 | 0.000 |
Why?
|
Aged | 1 | 2013 | 169266 | 0.000 |
Why?
|
Middle Aged | 1 | 2013 | 220835 | 0.000 |
Why?
|